1. Market Research
  2. > Pharmaceutical Market Trends
  3. > United States Blood Products Industry 2015 Market Research Report

United States Blood Products Industry 2015 Market Research Report

  • December 2015
  • -
  • QY Research Group
  • -
  • 135 pages

Summary


The United States Blood Products Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Blood Products industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Blood Products market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on United States major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Blood Products industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 148 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Table Of Contents

United States Blood Products Industry 2015 Market Research Report
Table of Contents

1 Industry Overview
1.1 Definition and Specifications of Blood Products
1.2 Classification of Blood Products
1.2.1 Alpha-1-Proteinase Inhibitor
1.2.2 Antihemophilic Factor
1.2.3 Antithrombin
1.2.4 C1 Esterase Inhibitor
1.2.5 Coagulation Factors
1.2.6 Immuno-Globulins
1.2.7 Protein C
1.2.8 Thrombin
1.3 Applications of Blood Products
1.4 Industry Chain Structure of Blood Products
1.5 Industry Overview of Blood Products
1.6 Industry Policy Analysis of Blood Products
1.7 Industry News Analysis of Blood Products

2 Manufacturing Cost Structure Analysis of Blood Products
2.1 Bill of Materials (BOM) of Blood Products
2.2 BOM Price Analysis of Blood Products
2.3 Labor Cost Analysis of Blood Products
2.4 Depreciation Cost Analysis of Blood Products
2.5 Manufacturing Cost Structure Analysis of Blood Products
2.6 Manufacturing Process Analysis of Blood Products
2.7 China Price, Cost and Gross of Blood Products 2010-2015

3 Technical Data and Manufacturing Plants Analysis
3.1 Capacity and Commercial Production Date of United States Key Manufacturers in 2014
3.2 Manufacturing Plants Distribution of United States Key Blood Products Manufacturers in 2014
3.3 RandD Status and Technology Source of United States Blood Products Key Manufacturers in 2014
3.4 Raw Materials Sources Analysis of United States Blood Products Key Manufacturers in 2014

4 Production Analysis of Blood Products by Regions, Type, and Applications
4.1 United States Production of Blood Products by Regions 2010-2015
4.2 United States Production of Blood Products by Type 2010-2015
4.3 United States Sales of Blood Products by Applications 2010-2015

4.4 Price Analysis of United States Blood Products Key Manufacturers in 2015
4.5 United States Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Blood Products 2010-2015

5 Consumption Volume and Consumption Value Analysis of Blood Products by Regions
5.1 United States Consumption Volume of Blood Products by Regions 2010-2015
5.2 United States Consumption Value of Blood Products by Regions 2010-2015
5.3 United States Consumption Price Analysis of Blood Products by Regions 2010-2015

6 Analysis of Blood Products Production, Supply, Sales and Market Status 2010-2015
6.1 Capacity, Production, Sales, and Revenue of Blood Products 2010-2015
6.2 Production Market Share and Sales Market Share Analysis of Blood Products 2014-2015
6.3 Sales Overview of Blood Products 2010-2015
6.4 Supply, Consumption and Gap of Blood Products 2010-2015
6.5 Import, Export and Consumption of Blood Products 2010-2015
6.6 Cost, Price, Revenue and Gross Margin of Blood Products 2010-2015

7 Analysis of Blood Products Industry Key Manufacturers
7.1 Abbott laboratories
7.1.1 Company Profile
7.1.2 Product Picture and Specification
7.1.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.1.4 Abbott laboratories SWOT Analysis

7.2 Affymax
7.2.1 Company Profile
7.2.2 Product Picture and Specification
7.2.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.2.4 Affymax SWOT Analysis

7.3 Alcon
7.3.1 Company Profile
7.3.2 Product Picture and Specification
7.3.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.3.4 Alcon SWOT Analysis

7.4 Alexion pharmaceuticals
7.4.1 Company Profile
7.4.2 Product Picture and Specification
7.4.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.4.4 Alexion pharmaceuticals SWOT Analysis

7.5 Allergan
7.5.1 Company Profile
7.5.2 Product Picture and Specification
7.5.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.5.4 Allergan SWOT Analysis

7.10 Biogen
7.10.1 Company Profile
7.10.2 Product Picture and Specification
7.10.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.10.4 Biogen SWOT Analysis

7.11 Biotest pharmaceuticals
7.11.1 Company Profile
7.11.2 Product Picture and Specification
7.11.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.11.4 Biotest pharmaceuticals SWOT Analysis

7.12 Boehringer ingelheim
7.12.1 Company Profile
7.12.2 Product Picture and Specification
7.12.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.12.4 Boehringer ingelheim SWOT Analysis

7.13 Bristol-myers squibb
7.13.1 Company Profile
7.13.2 Product Picture and Specification
7.13.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.13.4 Bristol-myers squibb SWOT Analysis

7.14 Btg international
7.14.1 Company Profile
7.14.2 Product Picture and Specification
7.14.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.14.4 Btg international SWOT Analysis

7.15 Cangene
7.15.1 Company Profile
7.15.2 Product Picture and Specification
7.15.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.15.4 Cangene SWOT Analysis

7.16 Csl
7.16.1 Company Profile
7.16.2 Product Picture and Specification
7.16.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.16.4 Csl SWOT Analysis

7.17 Dendreon
7.17.1 Company Profile
7.17.2 Product Picture and Specification
7.17.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.17.4 Dendreon SWOT Analysis

7.18 Eisai
7.18.1 Company Profile
7.18.2 Product Picture and Specification
7.18.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.18.4 Eisai SWOT Analysis

7.19 Eli lilly
7.19.1 Company Profile
7.19.2 Product Picture and Specification
7.19.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.19.4 Eli lilly SWOT Analysis

7.20 Ferring pharmaceuticals
7.20.1 Company Profile
7.20.2 Product Picture and Specification
7.20.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.20.4 Ferring pharmaceuticals SWOT Analysis

7.21 Fresenius kabi
7.21.1 Company Profile
7.21.2 Product Picture and Specification
7.21.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.21.4 Fresenius kabi SWOT Analysis

7.22 Glaxosmithkline
7.22.1 Company Profile
7.22.2 Product Picture and Specification
7.22.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.22.4 Glaxosmithkline SWOT Analysis

7.23 Grifols biologicals
7.23.1 Company Profile
7.23.2 Product Picture and Specification
7.23.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.23.4 Grifols biologicals SWOT Analysis

7.24 Hoffman-la-roche
7.24.1 Company Profile
7.24.2 Product Picture and Specification
7.24.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.24.4 Hoffman-la-roche SWOT Analysis

7.25 Hospira
7.25.1 Company Profile
7.25.2 Product Picture and Specification
7.25.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.25.4 Hospira SWOT Analysis

7.26 Janssen-cilag
7.26.1 Company Profile
7.26.2 Product Picture and Specification
7.26.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.26.4 Janssen-cilag SWOT Analysis

7.27 Johnson and johnson
7.27.1 Company Profile
7.27.2 Product Picture and Specification
7.27.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.27.4 Johnson and johnson SWOT Analysis

7.28 Kamada
7.28.1 Company Profile
7.28.2 Product Picture and Specification
7.28.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.28.4 Kamada SWOT Analysis

7.29 Kedrion biopharmaceuticals
7.29.1 Company Profile
7.29.2 Product Picture and Specification
7.29.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.29.4 Kedrion biopharmaceuticals SWOT Analysis

7.30 Lundbeck
7.30.1 Company Profile
7.30.2 Product Picture and Specification
7.30.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.30.4 Lundbeck SWOT Analysis

7.31 Medimmune
7.31.1 Company Profile
7.31.2 Product Picture and Specification
7.31.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.31.4 Medimmune SWOT Analysis

7.32 Merck
7.32.1 Company Profile
7.32.2 Product Picture and Specification
7.32.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.32.4 Merck SWOT Analysis

7.33 Mylan
7.33.1 Company Profile
7.33.2 Product Picture and Specification
7.33.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.33.4 Mylan SWOT Analysis

7.34 Nabi biopharmaceuticals (now biota pharmaceuticals)
7.34.1 Company Profile
7.34.2 Product Picture and Specification
7.34.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.34.4 Nabi biopharmaceuticals (now biota pharmaceuticals) SWOT Analysis

7.35 Novartis
7.35.1 Company Profile
7.35.2 Product Picture and Specification
7.35.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.35.4 Novartis SWOT Analysis

7.36 Novo nordisk
7.36.1 Company Profile
7.36.2 Product Picture and Specification
7.36.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.36.4 Novo nordisk SWOT Analysis

7.37 Octapharma pharmazeutika produktionsges.m.b.h
7.37.1 Company Profile
7.37.2 Product Picture and Specification
7.37.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.37.4 Octapharma pharmazeutika produktionsges.m.b.h SWOT Analysis

7.38 Omrix biopharmaceuticals
7.38.1 Company Profile
7.38.2 Product Picture and Specification
7.38.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.38.4 Omrix biopharmaceuticals SWOT Analysis

7.39 Pfizer
7.39.1 Company Profile
7.39.2 Product Picture and Specification
7.39.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.39.4 Pfizer SWOT Analysis

7.40 Protein sciences corporation
7.40.1 Company Profile
7.40.2 Product Picture and Specification
7.40.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.40.4 Protein sciences corporation SWOT Analysis

7.41 Rare disease therapeutics
7.41.1 Company Profile
7.41.2 Product Picture and Specification
7.41.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.41.4 Rare disease therapeutics SWOT Analysis

7.42 Revo biologics
7.42.1 Company Profile
7.42.2 Product Picture and Specification
7.42.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.42.4 Revo biologics SWOT Analysis

7.43 Sandoz
7.43.1 Company Profile
7.43.2 Product Picture and Specification
7.43.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.43.4 Sandoz SWOT Analysis

7.44 Sanofi
7.44.1 Company Profile
7.44.2 Product Picture and Specification
7.44.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.44.4 Sanofi SWOT Analysis

8 Price and Gross Margin Analysis
8.1 Analysis of Price
8.2 Gross Margin Analysis
8.3 Price Comparison by Regions
8.4 Price Analysis of Different Blood Products Product Types
8.5 Market Share Analysis of Different Blood Products Price Levels
8.6 Gross Margin Analysis of Different Blood Products Applications

9 Marketing Trader or Distributor Analysis of Blood Products
9.1 Marketing Channels Status of Blood Products
9.2 Traders or Distributors of Blood Products with Contact Information
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Blood Products
9.4 United States Import, Export and Trade Analysis of Blood Products

10 Development Trend of Blood Products Industry 2016-2021
10.1 Capacity and Production Overview of Blood Products 2016-2021
10.2 Production Market Share by Product Types of Blood Products 2016-2021
10.3 Sales and Sales Revenue Overview of Blood Products 2016-2021
10.4 United States Sales of Blood Products by Applications 2016-2021
10.5 Import, Export and Consumption of Blood Products 2016-2021
10.6 Cost, Price, Revenue and Gross Margin of Blood Products 2016-2021

11 Industry Chain Suppliers of Blood Products with Contact Information
11.1 Major Raw Materials Suppliers of Blood Products with Contact Information
11.2 Manufacturing Equipment Suppliers of Blood Products with Contact Information
11.3 Major Players of Blood Products with Contact Information
11.4 Key Consumers of Blood Products with Contact Information
11.5 Supply Chain Relationship Analysis of Blood Products

12 New Project Investment Feasibility Analysis of Blood Products
12.1 New Project SWOT Analysis of Blood Products
12.2 New Project Investment Feasibility Analysis of Blood Products

13 Conclusion of the United States Blood Products Industry 2015 Market Research Report




List of Tables and Figures

Figure Picture of Blood Products
Table Product Specifications of Blood Products
Table Classification of Blood Products
Figure United States Sales Market Share of Blood Products by Product Types in 2014
Table Applications of Blood Products
Figure United States Sales Market Share of Blood Products by Applications in 2014
Figure Industry Chain Structure of Blood Products
Table United States Industry Overview of Blood Products
Table Industry Policy of Blood Products
Table Industry News List of Blood Products
Table Bill of Materials (BOM) of Blood Products
Table Bill of Materials (BOM) Price of Blood Products
Table Labor Cost of Blood Products
Table Depreciation Cost of Blood Products
Table Manufacturing Cost Structure Analysis of Blood Products in 2014
Figure Manufacturing Process Analysis of Blood Products
Table United States Price Analysis of Blood Products 2010-2015 (USD/Dose)
Table United States Cost Analysis of Blood Products 2010-2015 (USD/Dose)
Table United States Gross Analysis of Blood Products 2010-2015
Table Capacity (Doses) and Commercial Production Date of United States Blood Products Key Manufacturers in 2014
Table Manufacturing Plants Distribution of United States Key Blood Products Manufacturers in 2014
Table RandD Status and Technology Source of United States Blood Products Key Manufacturers in 2014
Table Raw Materials Sources Analysis of United States and United States Blood Products Key Manufacturers in 2014
Table United States Production of Blood Products by Regions 2010-2015 (Doses)
Table United States Production Market Share of Blood Products by Regions 2010-2015
Figure United States Production Market Share of Blood Products by Regions in 2014
Figure United States Production Market Share of Blood Products by Regions in 2015
Table United States Production of Blood Products by Types in 2010-2015 (Doses)
Table United States Production Market Share of Blood Products by Type in 2010-2015
Figure United States Production Market Share of Blood Products by Type in 2014
Figure United States Production Market Share of Blood Products by Type in 2015
Table United States Sales of Blood Products by Applications 2010-2015 (Doses)
Table United States Production Market Share of Blood Products by Applications 2010-2015
Figure United States Production Market Share of Blood Products by Applications in 2014
Figure United States Production Market Share of Blood Products by Applications in 2015
Table Price Comparison of United States Blood Products Key Manufacturers in 2015 (USD/Dose)
Table United States Capacity, Production, Import Export Sales Price , Cost and Revenue (M USD) of Blood Products 2010-2015
Table United States Consumption Volume of Blood Products by Regions 2010-2015 (Doses)
Table United States Consumption Volume Market Share of Blood Products by Regions 2010-2015 (%)
Figure United States Consumption Volume Market Share of Blood Products by Regions in 2014
Figure United States Consumption Volume Market Share of Blood Products by Regions in 2015
Table United States Consumption Value of Blood Products by Regions 2010-2015 (M USD)
Table United States Consumption Value Market Share of Blood Products by Regions 2010-2015
Figure United States Consumption Value Market Share of Blood Products by Regions in 2014
Figure United States Consumption Value Market Share of Blood Products by Regions in 2015
Table Consumption Price of Blood Products by Regions 2010-2015 (USD/Dose)
Table United States and Major Manufacturers Capacity of Blood Products 2010-2015 (Doses)
Table United States Capacity Market Share of Major Blood Products Manufacturers 2010-2015
Table United States and Major Manufacturers Production of Blood Products 2010-2015 (Doses)
Table United States Production Market Share of Major Blood Products Manufacturers 2010-2015
Table United States and Major Manufacturers Sales of Blood Products 2010-2015 (Doses)
Table United States Sales Market Share of Major Blood Products Manufacturers 2010-2015
Table United States and Major Manufacturers Sales Revenue of Blood Products 2010-2015 (M USD)
Table United States Sales Revenue Market Share of Major Blood Products Manufacturers 2010-2015
Figure United States Capacity (Doses), Production (Doses) and Growth Rate of Blood Products 2010-2015
Figure United States Capacity Utilization Rate of Blood Products 2010-2015
Figure United States Sales Revenue (M USD) and Growth Rate of Blood Products 2010-2015
Figure United States Production Market Share of Major Blood Products Manufacturers in 2014
Figure United States Production Market Share of Major Blood Products Manufacturers in 2015
Figure United States Sales Market Share of Major Blood Products Manufacturers in 2014
Figure United States Sales Market Share of Major Blood Products Manufacturers in 2015
Figure United States Sales (Doses) and Growth Rate of Blood Products 2010-2015
Table United States Supply, Consumption and Gap of Blood Products 2010-2015 (Doses)
Table United States Import, Export and Consumption of Blood Products 2010-2015 (Doses)
Table Price of United States Blood Products Major Manufacturers 2010-2015 (USD/Dose)
Table Gross Margin of United States Blood Products Major Manufacturers 2010-2015
Table United States and Major Manufacturers Revenue of Blood Products 2010-2015 (M USD)
Table United States Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Blood Products 2010-2015
Table Abbott laboratories Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Blood Products Picture and Specifications of Abbott laboratories
Table Blood Products Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Abbott laboratories 2010-2015
Figure Blood Products Capacity (Doses), Production (Doses) and Growth Rate of Abbott laboratories 2010-2015
Figure Blood Products Production (Doses) and United States Market Share of Abbott laboratories 2010-2015
Table Abbott laboratories Blood Products SWOT Analysis
Table Affymax Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Blood Products Picture and Specifications of Affymax
Table Blood Products Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Affymax 2010-2015
Figure Blood Products Capacity (Doses), Production (Doses) and Growth Rate of Affymax 2010-2015
Figure Blood Products Production (Doses) and United States Market Share of Affymax 2010-2015
Table Affymax Blood Products SWOT Analysis
Table Alcon Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Blood Products Picture and Specifications of Alcon
Table Blood Products Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Alcon 2010-2015
Figure Blood Products Capacity (Doses), Production (Doses) and Growth Rate of Alcon 2010-2015
Figure Blood Products Production (Doses) and United States Market Share of Alcon 2010-2015
Table Alcon Blood Products SWOT Analysis
Table Alexion pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Blood Products Picture and Specifications of Alexion pharmaceuticals
Table Blood Products Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Alexion pharmaceuticals 2010-2015
Figure Blood Products Capacity (Doses), Production (Doses) and Growth Rate of Alexion pharmaceuticals 2010-2015
Figure Blood Products Production (Doses) and United States Market Share of Alexion pharmaceuticals 2010-2015
Table Alexion pharmaceuticals Blood Products SWOT Analysis
Table Allergan Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Blood Products Picture and Specifications of Allergan
Table Blood Products Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Allergan 2010-2015
Figure Blood Products Capacity (Doses), Production (Doses) and Growth Rate of Allergan 2010-2015
Figure Blood Products Production (Doses) and United States Market Share of Allergan 2010-2015
Table Allergan Blood Products SWOT Analysis
Table Biogen Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Blood Products Picture and Specifications of Biogen
Table Blood Products Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Biogen 2010-2015
Figure Blood Products Capacity (Doses), Production (Doses) and Growth Rate of Biogen 2010-2015
Figure Blood Products Production (Doses) and United States Market Share of Biogen 2010-2015
Table Biogen Blood Products SWOT Analysis
Table Biotest pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Blood Products Picture and Specifications of Biotest pharmaceuticals
Table Blood Products Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Biotest pharmaceuticals 2010-2015
Figure Blood Products Capacity (Doses), Production (Doses) and Growth Rate of Biotest pharmaceuticals 2010-2015
Figure Blood Products Production (Doses) and United States Market Share of Biotest pharmaceuticals 2010-2015
Table Biotest pharmaceuticals Blood Products SWOT Analysis
Table Boehringer ingelheim Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Blood Products Picture and Specifications of Boehringer ingelheim
Table Blood Products Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Boehringer ingelheim 2010-2015
Figure Blood Products Capacity (Doses), Production (Doses) and Growth Rate of Boehringer ingelheim 2010-2015
Figure Blood Products Production (Doses) and United States Market Share of Boehringer ingelheim 2010-2015
Table Boehringer ingelheim Blood Products SWOT Analysis
Table Bristol-myers squibb Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Blood Products Picture and Specifications of Bristol-myers squibb
Table Blood Products Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Bristol-myers squibb 2010-2015
Figure Blood Products Capacity (Doses), Production (Doses) and Growth Rate of Bristol-myers squibb 2010-2015
Figure Blood Products Production (Doses) and United States Market Share of Bristol-myers squibb 2010-2015
Table Bristol-myers squibb Blood Products SWOT Analysis
Table Btg international Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Blood Products Picture and Specifications of Btg international
Table Blood Products Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Btg international 2010-2015
Figure Blood Products Capacity (Doses), Production (Doses) and Growth Rate of Btg international 2010-2015
Figure Blood Products Production (Doses) and United States Market Share of Btg international 2010-2015
Table Btg international Blood Products SWOT Analysis
Table Cangene Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Blood Products Picture and Specifications of Cangene
Table Blood Products Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Cangene 2010-2015
Figure Blood Products Capacity (Doses), Production (Doses) and Growth Rate of Cangene 2010-2015
Figure Blood Products Production (Doses) and United States Market Share of Cangene 2010-2015
Table Cangene Blood Products SWOT Analysis
Table Csl Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Blood Products Picture and Specifications of Csl
Table Blood Products Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Csl 2010-2015
Figure Blood Products Capacity (Doses), Production (Doses) and Growth Rate of Csl 2010-2015
Figure Blood Products Production (Doses) and United States Market Share of Csl 2010-2015
Table Csl Blood Products SWOT Analysis
Table Dendreon Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Blood Products Picture and Specifications of Dendreon
Table Blood Products Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Dendreon 2010-2015
Figure Blood Products Capacity (Doses), Production (Doses) and Growth Rate of Dendreon 2010-2015
Figure Blood Products Production (Doses) and United States Market Share of Dendreon 2010-2015
Table Dendreon Blood Products SWOT Analysis
Table Eisai Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Blood Products Picture and Specifications of Eisai
Table Blood Products Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Eisai 2010-2015
Figure Blood Products Capacity (Doses), Production (Doses) and Growth Rate of Eisai 2010-2015
Figure Blood Products Production (Doses) and United States Market Share of Eisai 2010-2015
Table Eisai Blood Products SWOT Analysis
Table Eli lilly Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Blood Products Picture and Specifications of Eli lilly
Table Blood Products Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Eli lilly 2010-2015
Figure Blood Products Capacity (Doses), Production (Doses) and Growth Rate of Eli lilly 2010-2015
Figure Blood Products Production (Doses) and United States Market Share of Eli lilly 2010-2015
Table Eli lilly Blood Products SWOT Analysis
Table Ferring pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Blood Products Picture and Specifications of Ferring pharmaceuticals
Table Blood Products Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Ferring pharmaceuticals 2010-2015
Figure Blood Products Capacity (Doses), Production (Doses) and Growth Rate of Ferring pharmaceuticals 2010-2015
Figure Blood Products Production (Doses) and United States Market Share of Ferring pharmaceuticals 2010-2015
Table Ferring pharmaceuticals Blood Products SWOT Analysis
Table Fresenius kabi Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Blood Products Picture and Specifications of Fresenius kabi
Table Blood Products Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Fresenius kabi 2010-2015
Figure Blood Products Capacity (Doses), Production (Doses) and Growth Rate of Fresenius kabi 2010-2015
Figure Blood Products Production (Doses) and United States Market Share of Fresenius kabi 2010-2015
Table Fresenius kabi Blood Products SWOT Analysis
Table Glaxosmithkline Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Blood Products Picture and Specifications of Glaxosmithkline
Table Blood Products Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Glaxosmithkline 2010-2015
Figure Blood Products Capacity (Doses), Production (Doses) and Growth Rate of Glaxosmithkline 2010-2015
Figure Blood Products Production (Doses) and United States Market Share of Glaxosmithkline 2010-2015
Table Glaxosmithkline Blood Products SWOT Analysis
Table Grifols biologicals Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Blood Products Picture and Specifications of Grifols biologicals
Table Blood Products Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Grifols biologicals 2010-2015
Figure Blood Products Capacity (Doses), Production (Doses) and Growth Rate of Grifols biologicals 2010-2015
Figure Blood Products Production (Doses) and United States Market Share of Grifols biologicals 2010-2015
Table Grifols biologicals Blood Products SWOT Analysis
Table Hoffman-la-roche Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Blood Products Picture and Specifications of Hoffman-la-roche
Table Blood Products Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Hoffman-la-roche 2010-2015
Figure Blood Products Capacity (Doses), Production (Doses) and Growth Rate of Hoffman-la-roche 2010-2015
Figure Blood Products Production (Doses) and United States Market Share of Hoffman-la-roche 2010-2015
Table Hoffman-la-roche Blood Products SWOT Analysis
Table Hospira Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Blood Products Picture and Specifications of Hospira
Table Blood Products Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Hospira 2010-2015
Figure Blood Products Capacity (Doses), Production (Doses) and Growth Rate of Hospira 2010-2015
Figure Blood Products Production (Doses) and United States Market Share of Hospira 2010-2015
Table Hospira Blood Products SWOT Analysis
Table Janssen-cilag Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Blood Products Picture and Specifications of Janssen-cilag
Table Blood Products Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Janssen-cilag 2010-2015
Figure Blood Products Capacity (Doses), Production (Doses) and Growth Rate of Janssen-cilag 2010-2015
Figure Blood Products Production (Doses) and United States Market Share of Janssen-cilag 2010-2015
Table Janssen-cilag Blood Products SWOT Analysis
Table Johnson and johnson Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Blood Products Picture and Specifications of Johnson and johnson
Table Blood Products Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Johnson and johnson 2010-2015
Figure Blood Products Capacity (Doses), Production (Doses) and Growth Rate of Johnson and johnson 2010-2015
Figure Blood Products Production (Doses) and United States Market Share of Johnson and johnson 2010-2015
Table Johnson and johnson Blood Products SWOT Analysis
Table Kamada Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Blood Products Picture and Specifications of Kamada
Table Blood Products Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Kamada 2010-2015
Figure Blood Products Capacity (Doses), Production (Doses) and Growth Rate of Kamada 2010-2015
Figure Blood Products Production (Doses) and United States Market Share of Kamada 2010-2015
Table Kamada Blood Products SWOT Analysis
Table Kedrion biopharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Blood Products Picture and Specifications of Kedrion biopharmaceuticals
Table Blood Products Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Kedrion biopharmaceuticals 2010-2015
Figure Blood Products Capacity (Doses), Production (Doses) and Growth Rate of Kedrion biopharmaceuticals 2010-2015
Figure Blood Products Production (Doses) and United States Market Share of Kedrion biopharmaceuticals 2010-2015
Table Kedrion biopharmaceuticals Blood Products SWOT Analysis
Table Lundbeck Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Blood Products Picture and Specifications of Lundbeck
Table Blood Products Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Lundbeck 2010-2015
Fi

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.